Mark Emmanuel Cooper

8PUBLICATIONS
32CO-AUTHORS
Major global burdens of diseaseNutrigenomics and personalised nutritionCardiology (incl. cardiovascular diseases)Molecular targetsSocio-economic development
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 29, 2026
EZH2 inhibition via GSK-126 mitigates EndMT and atherosclerosis in diabetes: A translational epigenetic approach.

|Jun 06, 2025
Kidney Disease: The Forgotten Legacy of Type 1 Diabetes.

Merlin C Thomas, Sophia Zoungas, Nordin M J Hanssen

|Nov 20, 2024
Lipoxin A<sub>4</sub> improves cardiac remodeling and function in diabetes-associated cardiac dysfunction.

Ting Fu, Muthukumar Mohan, Madhura Bose

|Jun 21, 2024
The Role of Activator Protein-1 Complex in Diabetes-Associated Atherosclerosis: Insights From Single-Cell RNA Sequencing.

Abdul Waheed Khan, Misbah Aziz, Karly C Sourris

|May 19, 2022
Low- and middle-income countries demonstrate rapid growth of type 2 diabetes: an analysis based on Global Burden of Disease 1990-2019 data.

Jinli Liu, Ruhai Bai, Zhonglin Chai

|May 26, 2021
The Impact of Frailty on the Effectiveness and Safety of Intensive Glucose Control and Blood Pressure-Lowering Therapy for People With Type 2 Diabetes: Results From the ADVANCE Trial.

Tu N Nguyen, Katie Harris, Mark Woodward

Pageof 2

Frequent Collaborators

2 joint publications

Abdul Waheed Khan

2 joint publications

Karin Agnes Maria Jandeleit-Dahm

1 joint publications

Tu N Nguyen

1 joint publications

Mark Woodward